| pubmed-article:16169682 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16169682 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:16169682 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:16169682 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:16169682 | lifeskim:mentions | umls-concept:C0002844 | lld:lifeskim |
| pubmed-article:16169682 | lifeskim:mentions | umls-concept:C0871712 | lld:lifeskim |
| pubmed-article:16169682 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:16169682 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16169682 | pubmed:dateCreated | 2005-11-21 | lld:pubmed |
| pubmed-article:16169682 | pubmed:abstractText | To compare several characteristics of alternative definitions of biochemical failure (BF) in men with extended follow-up after radiotherapy (RT) with or with androgen deprivation therapy (ADT) for prostate cancer. | lld:pubmed |
| pubmed-article:16169682 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16169682 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169682 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16169682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169682 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16169682 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16169682 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:16169682 | pubmed:author | pubmed-author:UzzoRobert... | lld:pubmed |
| pubmed-article:16169682 | pubmed:author | pubmed-author:FeigenbergSte... | lld:pubmed |
| pubmed-article:16169682 | pubmed:author | pubmed-author:HanlonAlexand... | lld:pubmed |
| pubmed-article:16169682 | pubmed:author | pubmed-author:HorwitzEric... | lld:pubmed |
| pubmed-article:16169682 | pubmed:author | pubmed-author:PollackAlanA | lld:pubmed |
| pubmed-article:16169682 | pubmed:author | pubmed-author:BuyyounouskiM... | lld:pubmed |
| pubmed-article:16169682 | pubmed:author | pubmed-author:EisenbergDebr... | lld:pubmed |
| pubmed-article:16169682 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16169682 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16169682 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:16169682 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16169682 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16169682 | pubmed:pagination | 1455-62 | lld:pubmed |
| pubmed-article:16169682 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:meshHeading | pubmed-meshheading:16169682... | lld:pubmed |
| pubmed-article:16169682 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16169682 | pubmed:articleTitle | Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. | lld:pubmed |
| pubmed-article:16169682 | pubmed:affiliation | Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. mark.buyyounouski@fccc.edu | lld:pubmed |
| pubmed-article:16169682 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16169682 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16169682 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16169682 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16169682 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16169682 | lld:pubmed |
